Pieris Pharmaceuticals
PIRS
$8.71
Share price
0.58%
Change (1 day)
4,484.21%
Change (1 year)
Categories
Pieris Pharmaceuticals (PIRS) - Cash on Hand
Cash on Hand as of March 2024 : $19.08 M
According to Pieris Pharmaceuticals's latest financial reports the company has $19.08 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Pieris Pharmaceuticals - Cash on Hand chart (from 2013 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $59.16 M | -49.76% |
| 2021-12-31 | $0.11 B | 67.19% |
| 2020-12-31 | $70.43 M | -32.37% |
| 2019-12-31 | $0.10 B | -18.7% |
| 2018-12-31 | $0.12 B | 76.39% |
| 2017-12-31 | $72.62 M | 147.41% |
| 2016-12-31 | $29.35 M | 0.02% |
| 2015-12-31 | $29.34 M | 58.87% |
| 2014-12-31 | $18.47 M | 400.74% |
| 2014-06-30 | $0.01 M | 114.19% |
| 2013-12-31 | $3.68 M | |
| 2013-06-30 | $0 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $4.71 B | 24,622.28% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | N/A | N/A | 🇺🇸 USA |
 Aeterna Zentaris AEZS | $29.54 M | 54.82% | 🇺🇸 USA |